Join us for a 90-minute training session for new users of QIAGEN IPA. In this training, you’ll learn how to: • Upload your dataset (RNA-seq, scRNA-seq, proteomics, metabolomics and more) and perform interactive core/pathway analysis in IPA • Understand the different result types produced (pathways, key regulators, impact on biological functions/diseases and more) • Compare […]
Research and development for new drugs and disease treatments can be lengthy and costly. Indication expansion can help broaden the impact of a new drug that has already been through the arduous R&D process for a disease or cancer. Drug repurposing can take this concept and expand on it by looking for other diseases with […]
Genome-wide association studies (GWAS) provide insights into the genetic architecture of disease by identifying susceptibility loci for the disease within a population. If you'd like to identify disease genes and novel biological pathways that underlay the disease pathogenesis to identify novel drug targets, QIAGEN Ingenuity Pathway Analysis (IPA) helps you characterize and validate risk loci […]
This two-part series will walk you through single-cell RNA sequencing (scRNA-seq) analysis starting with a matrix file or FASTQ files and ending with a deep understanding of key pathways, regulators and cell type signatures within your data. This session is for part I of this training. In this session, you'll learn to use QIAGEN CLC […]
This two-part series will walk you through single-cell RNA sequencing (scRNA-seq) analysis starting with a matrix file or FASTQ files and ending with a deep understanding of key pathways, regulators […]
The composition of the immune repertoire, consisting of the T cell and B cell receptors (TCR and BCR), is important for an organism's adaptive immune system and plays a pivotal […]
Take your QIAGEN Ingenuity Pathway Analysis (IPA) analyses to the next level by comparing them to your own analyses (different time points, treatments, cell lines, diseased and more) or to […]
In this 90-minute training, you'll learn how to perform drug treatment, toxicology and target safety assessment-related discoveries using QIAGEN Ingenuity Pathway Analysis (IPA) and QIAGEN Omicsoft Lands. Using public data […]
Join us for a 120-minute training session for new users of QIAGEN IPA. Users will learn how to: • Upload their dataset (RNA-seq, scRNA-seq, proteomics, metabolomics and more) and perform […]
When it comes to taxonomic profiling of the microbiome, amplicon sequence variants (ASVs) is a method that has unique benefits compared to the traditional method of sequence similarity-based operational taxonomic […]
QIAGEN Ingenuity Pathway Analysis (IPA) represents a robust resource to aid in the process of writing grants publications. Driven by a wealth of manually-curated molecular interactions and associations in the QIAGEN Knowledge Base together with pre-analyzed public ‘omics data for hundreds of thousands of samples from QIAGEN OmicSoft Lands, IPA provides biological insights regardless of […]
If you’re a data scientist or bioinformatician working in biopharma and need extensive high-quality ‘omics data for your projects in target discovery, this training is for you. You’ll learn how to programmatically discover, retrieve, filter, aggregate and analyze ‘omics data from our extensive repositories of deeply-curated multi-omics data. You’ll learn how to leverage extensive metadata […]
Industry leaders discuss how to improve the speed, precision and cost-effectiveness of clinical exome testing for newborn screening and rare and undiagnosed diseases Clinical exome testing is revolutionizing the diagnosis of rare and inherited diseases. Its ability to quickly pinpoint the genetic causes of complex conditions has made it a critical component of personalized medicine, […]
Watch NowIn this training, you will learn how to analyze viral samples using QIAGEN CLC Genomics Workbench. This webinar will focus on bioinformatics workflows and data interpretation using H5N1 as an example, but similar analysis can be done with other viral and microbial (bacteria, fungus and more) samples. Using viral samples, you will learn how to: […]
Watch NowMore and more biopharma and academic groups are looking to process a large number of samples simultaneously or for a quicker turnaround time. This webinar will introduce a flexible and powerful setup for running your NGS sequence analyses through servers or Amazon Web Services (AWS), depending on user preference. We will demonstrate how CLC Genomics […]
Watch NowThere is a strong interest in the scientific community to use public (GEO, SRA, TCGA, LINCS, etc.) omics (RNA-seq, scRNA-seq, microarray, proteomics, etc.) data for a variety of discoveries. This webinar, aimed at data scientists, bioinformaticians and similar roles in biopharma and academia, explores a comprehensive way of accessing and analyzing high-quality, expertly curated omics […]
Watch NowYou’re invited to attend the 2024 Clinician’s Roundtable, a virtual event where medical directors and oncologists will discuss how to better interpret genomic test results to tailor treatment strategies for cancer patients. As the role of the Molecular Tumor Board (MTB) becomes increasingly important in the implementation of evidence-based precision cancer medicine programs, molecular pathology […]
Watch NowIngenuity Pathway Analysis (IPA), currently cited in tens of thousands of publications and used by a large number of biopharmaceutical companies, is backed by QIAGEN Biomedical KB-HD. Accordingly, biomedical relationships knowledge has practically become required for innovative data- and analytics-driven drug discovery. It powers biomedical knowledge graph analysis, artificial intelligence (AI)-driven target identification and many […]
Watch Now
